Johns Hopkins is conducting an FDA-registered clinical trial to treat mild cognitive impairment, a condition that increases risk for Alzheimer's disease. Older adults, ages 55 to 85, who have been diagnosed with mild cognitive impairment, or are experiencing symptoms such as forgetfulness, getting lost, or often misplacing items, may be eligible to participate in this research study. Three screening visits to qualify for participation include a medical assessment with PET and MRI scans to image your brain. Eligible participants will take either the study drug or a placebo once daily for 18 months. Participants will be compensated for their time.
Contact the study team at 410-502-4797 or email hope4mci@jhu.edu for more information.
Principal investigator: Dr. Marilyn Albert
IRB Protocol #: IRB000101152
